Author

Thalia Papayannopoulou

University of WashingtonORCID 0000-0002-4523-1393Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Thalia Papayannopoulou1 paper · Division of Hematology, Department of Medicine, University of Washington , Seattle, WA 98185 ,

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ChIP-seq· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Alexandra KirtsouiD· 1 shared Evangelia YannakiiD· 1 shared George Stamatoyannopoulos· 1 shared Grigorios GeorgolopoulosiD· 1 shared Hao WangiD· 1 shared Jeff D. VierstraiD· 1 shared John A. StamatoyannopoulosiD· 1 shared Jordan E. Bloom· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alexandra KirtsouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

GenomicsbioRxivPreprintOct 4, 2023

Large-scale discovery of potent, compact and lineage specific enhancers for gene therapy vectors

Nikoletta Psatha, Pavel Sova, Grigorios Georgolopoulos…·Jeff D. Vierstra

The paper identifies potent, compact, and lineage-specific enhancers for gene therapy vectors using epigenomic data and validates their efficacy in correcting a thalassemia phenotype.

1 citation

humanDNA methylation